Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Lymphoma | Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1/Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | Phase 2 | ClinicalTrials |
| Esophageal Neoplasms; Stomach Neoplasms | Phase 1 | ClinicalTrials |
| Myeloproliferative Disorders; Polycythemia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thrombocytosis | Phase 2 | ClinicalTrials |
| Stomach Neoplasms | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Hematologic Neoplasms; Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Adenocarcinoma; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Adenocarcinoma; Colonic Neoplasms; Rectal Neoplasms | Phase 1 | ClinicalTrials |
| Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | Phase 2 | ClinicalTrials |
CONTENTS